13250-96-9 Usage
Description
Ethyl 4-hydroxy-7-methyl-1,8-naphthyridine-3-carboxylate is an organic compound with a unique chemical structure that features a naphthyridine ring and a carboxylate group. It is known for its potential applications in the pharmaceutical and chemical industries due to its reactivity and functional groups.
Uses
Used in Pharmaceutical Industry:
Ethyl 4-hydroxy-7-methyl-1,8-naphthyridine-3-carboxylate is used as a reagent for the synthesis of flavoquinolones, which are compounds that may exhibit antibacterial properties. Its role in the synthesis process is crucial for the development of new antibiotics to combat bacterial infections.
Used in Chemical Synthesis:
In the field of chemical synthesis, ethyl 4-hydroxy-7-methyl-1,8-naphthyridine-3-carboxylate serves as an intermediate or building block for the creation of more complex molecules with various applications. Its unique structure and functional groups make it a valuable component in the synthesis of a wide range of compounds.
Synthesis Reference(s)
Journal of the American Chemical Society, 70, p. 3348, 1948 DOI: 10.1021/ja01190a038
Check Digit Verification of cas no
The CAS Registry Mumber 13250-96-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,2,5 and 0 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 13250-96:
(7*1)+(6*3)+(5*2)+(4*5)+(3*0)+(2*9)+(1*6)=79
79 % 10 = 9
So 13250-96-9 is a valid CAS Registry Number.
InChI:InChI=1/C12H12N2O3/c1-3-17-12(16)9-6-13-11-8(10(9)15)5-4-7(2)14-11/h4-6H,3H2,1-2H3,(H,13,14,15)
13250-96-9Relevant articles and documents
Synthesis of selected novel covalently linked flavoquinolones
Singh, Ram,Geetanjali
, p. 2315 - 2320 (2007/10/03)
The synthesis of novel covalently linked flavoquinolones via amide bond is described using mixed anhydride method and their spectroscopic studies have been done by UV/Vis and 1H NMR spectroscopic data. Georg Thieme Verlag Stuttgart.
Ortho-sulfonamido bicyclic hydroxamic acids as matrix metalloproteinase and TACE inhibitors
-
, (2008/06/13)
This invention provides, low molecular weight, non-peptide inhibitors of matrix metalloproteinases and TNF-α converting enzyme (TACE, tumor necrosis factor-α converting enzyme) of formula: B wherein B is P and Q are provided that when P is Q is and vice versa; or a pharmaceutically acceptable salt thereof.
